XOLAIR
Live / Registered — Registered — Section 71 accepted (as of 08 Jan 2025)
What this means for you
Registered since 26 Aug 2014. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79143692
- Registration number
- 4590913
- Mark type
- Design + words
- Filed
- 05 Feb 2014
- Published for opposition
- 10 Jun 2014
- Registered
- 26 Aug 2014
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the prevention and treatment of urticaria
Owner
- NOVARTIS AG, Basel, CH
- NOVARTIS AG, CH
- NOVARTIS AG, CH
Prior registrations
Prosecution history
- 08 Jan 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 08 Jan 2025 — REGISTERED-SEC.71 ACCEPTED
- 06 Jan 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Jun 2024 — TEAS SECTION 71 RECEIVED
- 20 Oct 2023 — INTERNATIONAL REGISTRATION RENEWED
- 26 Aug 2023 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 19 Nov 2020 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 19 Nov 2020 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 19 Nov 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 06 Jul 2020 — TEAS SECTION 71 & 15 RECEIVED
- 09 Oct 2019 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 26 Aug 2019 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 19 Feb 2015 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 04 Feb 2015 — FINAL DISPOSITION NOTICE SENT TO IB
- 04 Feb 2015 — FINAL DISPOSITION PROCESSED